Karyopharm Announces FDA Approval of XPOVIO® (selinexor) for the Treatment of Patients with Relapsed or Refractory
Karyopharm Therapeutics Empresa reivindicada
Karyopharm is an innovation-driven pharmaceutical company whose core technology leverages the inhibition of nuclear export as a mechanism to treat patients with cancer and other medical conditions consulte Mais informação
Stock. Additional stock would be great incentive.
Quais são algumas das melhores coisas da sua equipe?
My team works hard, is dedicated and supportive of one another.
O que você mais gosta nos lideres?
The team is nimble and willing to take swift action with matters that affect business.
O que faz você mais feliz no trabalho?
It’s fulfilling to pull through initiatives and projects successfully. It’s also nice to feel appreciated or recognition for succe
Qual é a coisa mais positiva da cultura e do ambiente da sua empresa?
Executive team is supportive and generally willing to take swift action when needed. Innovation and urgency enable a healthy nimble environment.
Other Employee Reviews for Karyopharm Therapeutics
×